• By Jim McVeigh

Dignity Health-St. Rose Dominican adds Mayo Clinic “Telestroke”

February 16, 2015

3103728_0019[1]Henderson, Nev. – Southern Nevada residents in need of emergency medical care for a stroke may benefit from a Mayo Clinic “telestroke” program that is now available at all three campuses of Dignity Health-St. Rose Dominican (Rose de Lima, Siena and San Martín). A recent agreement between St. Rose and Mayo Clinic in Arizona means the service featuring a portable, self-propelled robot has begun in southern Nevada. This service will compliment and augment the already robust certified stroke centers at all three campuses and Dignity Health is the first to partner with Mayo on this project in Nevada.

In telestroke care, the use of a telestroke robot located in a hospital lets a stroke patient be seen in real time by a neurology specialist at Mayo Clinic located in Phoenix. The Mayo stroke neurologist, whose face appears on the screen of the robot, consults with emergency room physicians at the sites and evaluates the patient.

Patients showing signs of stroke can be examined by the neurologist via computer, smart phone technology, portable tablets or laptops. In addition to assessment of the patient, the neurologist can view scans of the patient's brain to detect possible damage from a hemorrhage or blocked artery.

"Excellent, capable emergency physicians at Dignity Health-St. Rose Dominican can ring the telestroke hotline and be instantly connected with Mayo Clinic's stroke experts," said Bart Demaerschalk, M.D., Professor of Neurology, and medical director of Mayo Clinic Telestroke. "Urgent and immediate virtual care can be provided to patients - collaboration between stroke neurologists and physicians at the remote sites has resulted in 96 percent accuracy in diagnosing stroke."

Brian Brannman, senior vice president of operations at Dignity Health-St. Rose Dominican stated, “Our mission is to provide quality health and wellness services where the patient, family and community come first.  This newly formed relationship with the Mayo Clinic is another step towards achieving that mission.  In collaboration with the stroke neurologists and our Emergency Department providers, immediate, life-saving interventions can begin shortly after the patient enters the ED.  This new service affords the patient care in a collaborative setting and will ultimately save lives. We are very excited to be able to offer this service to the communities we serve.”

Mayo Clinic was the first medical center in Arizona to do pioneering clinical research to study telemedicine as a means of serving patients with a stroke, and today serves as the "hub" in a network of 16 other "spoke" centers, with most in Arizona. To date, more than 1,500 emergency consultations for stroke have taken place between Mayo Clinic stroke neurologists and physicians at the spoke centers.

About Dignity Health-St. Rose Dominican
As the community’s only not-for-profit, religiously sponsored hospital system, Dignity Health-St. Rose Dominican has been guided by the vision and core values of the Adrian Dominican Sisters for more than 65 years. As the Henderson and Las Vegas communities grow, the three Dignity Health-St. Rose Dominican hospitals (the Rose de Lima, Siena and San Martín Campuses) and their more than 3,400 employees will continue the Sisters’ mission of serving people in need. Dignity Health-St. Rose Dominican is a member of the Dignity Health network of more than 300 care centers, including hospitals, urgent and occupational care, imaging centers, home health and primary care clinics. For more information, visit our website at http://www.strosehospitals.org or follow us on Facebook, Twitter, YouTube or our Blog.

###

About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to medical research and education, and providing expert, whole-person care to everyone who needs healing. For more information, visit http://mayocl.in/1ohJTMS, or http://newsnetwork.mayoclinic.org/.

MEDIA CONTACT: Jim McVeigh, Mayo Clinic Public Affairs, 507-284-5005, [email protected]
Katie Ryan, Dignity Health, 702-616-4847, [email protected]

Please login or become a member to post a comment.

(A)	Tissue staining comparing SCD1 protein expression in normal thyroid tissue, and anaplastic thyroid carcinoma (ATC). A Hematoxylin counter-stain (light blue) highlights the nuclei of the cells within each tissue section. The punctate dark brown stain within the cells indicates positive SCD1 protein expression. Little positive staining is observed in the normal tissue, however SCD1 is highly expressed in anaplastic thyroid carcinoma tissue suggesting that SCD1 is over-expressed in a tumor-specific manner. 

(B)	Tissue staining comparing Ki67- a nuclear protein that serves as a marker for cell growth, in placebo treated or combination SCD1 inhibitor and Carfilzomib (proteasome inhibitor) treated ATC tumors. A Hematoxylin counter-stain (light blue) highlights the nuclei of the cells within each tissue section. Positive Ki67 stain will color the nuclei brown, and increased Ki67 indicates a faster rate of tumor cell growth. The placebo treated tumors have high levels of Ki67 positive staining compared to the combination treated tumors, indicating that this treatment successfully slows the growth rate of ATC.